Longitudinal Association of Obesity, Metabolic Syndrome and Diabetes with Risk of Elevated Aminotransferase Levels in a Cohort of Mexican Health Workers

Overview

Journal J Dig Dis

Specialty Gastroenterology

Date 2016 Mar 19

PMID 26991251

Citations 7

Authors

Yvonne N Flores

Allyn Auslander

Catherine M Crespi

Michael Rodriguez

Zuo-Feng Zhang

Francisco Durazo

Jorge Salmeron

Affiliations

Soon will be listed here.

Abstract

Objective: In Mexico, chronic liver disease have been increasingly found along with the rapidly growing prevalence of obesity, diabetes and metabolic syndrome (MS). We aimed to investigate the longitudinal association between these three factors and risk of elevated alanine aminotransferase (ALT) levels (>40 U/L), a marker for liver damage, in a cohort of Mexican adults.

Methods: Data were obtained from two separate waves of the Mexican Health Worker Cohort Study: Wave 1 (2004-2006) and Wave 2 (2011-2013). Unconditional logistic regression models were employed to determine the cross-sectional and longitudinal association between these risk factors and elevated ALT levels.

Results: The prevalence of elevated ALT was significantly higher among men, individuals aged under 60 years, those who were overweight or obese, diabetic, with MS or heavy/binge drinkers. The longitudinal results indicated that weight gain between waves that resulted in a change in body mass index, along with remaining overweight or obese, were significantly associated with an increased risk of elevated ALT levels. A significantly increased risk of developing elevated ALT was also observed among those who acquired diabetes or MS from Wave 1 to Wave 2.

Conclusions: Weight gain and acquiring diabetes or MS are associated with a significant risk of having elevated ALT. These results, within the context of the rapid increase in global obesity rates, call urgently for programs to help to prevent chronic liver disease.

Citing Articles

Association between obesity indicators and cardiometabolic disease in Chinese adults.

Wu J, Zou L, Liu Y, Yu H, Yin H, Zhong L PLoS One. 2023; 18(1):e0273235.

PMID: 36662790 PMC: 9858028. DOI: 10.1371/journal.pone.0273235.

Is elevated ALT associated with lifestyle risk factors? A population-based survey.

Balali P, Nasserinejad M, Azadnajafabad S, Ahmadi N, Delavari F, Rashidian L J Diabetes Metab Disord. 2022; 21(2):1743-1751.

PMID: 36404851 PMC: 9672187. DOI: 10.1007/s40200-022-01137-6.

Prevalence and associated factors of obesity and overweight in Chinese patients with bipolar disorder.

Yi W, Wu H, Li R, Li H, Song Z, She S Front Psychiatry. 2022; 13:984829.

PMID: 36147966 PMC: 9485538. DOI: 10.3389/fpsyt.2022.984829.

Sugar-sweetened beverage consumption and risk of hyperuricemia: a longitudinal analysis of the Health Workers Cohort Study participants in Mexico.

Meneses-Leon J, Leon-Maldonado L, Macias N, Torres-Ibarra L, Hernandez-Lopez R, Rivera-Paredez B Am J Clin Nutr. 2020; 112(3):652-660.

PMID: 32644154 PMC: 7458765. DOI: 10.1093/ajcn/nqaa160.

Risk of developing pre-diabetes or diabetes over time in a cohort of Mexican health workers.

Flores Y, Toth S, Crespi C, Ramirez-Palacios P, McCarthy W, Briseno-Perez A PLoS One. 2020; 15(3):e0229403.

PMID: 32210432 PMC: 7094846. DOI: 10.1371/journal.pone.0229403.

References

Pan J, Qu H, Rentfro A, McCormick J, Fisher-Hoch S, Fallon M . Prevalence of metabolic syndrome and risks of abnormal serum alanine aminotransferase in Hispanics: a population-based study. PLoS One. 2011; 6(6):e21515. PMC: 3123360. DOI: 10.1371/journal.pone.0021515. View

Larrieta-Carrasco E, Acuna-Alonzo V, Velazquez-Cruz R, Barquera-Lozano R, Leon-Mimila P, Villamil-Ramirez H . PNPLA3 I148M polymorphism is associated with elevated alanine transaminase levels in Mexican Indigenous and Mestizo populations. Mol Biol Rep. 2014; 41(7):4705-11. DOI: 10.1007/s11033-014-3341-0. View

Mendez-Hernandez P, Flores Y, Siani C, Lamure M, Dosamantes-Carrasco L, Halley-Castillo E . Physical activity and risk of metabolic syndrome in an urban Mexican cohort. BMC Public Health. 2009; 9:276. PMC: 2734848. DOI: 10.1186/1471-2458-9-276. View

Rivera J, Barquera S, Gonzalez-Cossio T, Olaiz G, Sepulveda J . Nutrition transition in Mexico and in other Latin American countries. Nutr Rev. 2004; 62(7 Pt 2):S149-57. DOI: 10.1111/j.1753-4887.2004.tb00086.x. View

Watanabe S, Yaginuma R, Ikejima K, Miyazaki A . Liver diseases and metabolic syndrome. J Gastroenterol. 2008; 43(7):509-18. DOI: 10.1007/s00535-008-2193-6. View

Zheng R, Chen Z, Chen J, Lu Y, Chen J . Role of Body Mass Index, Waist-to-Height and Waist-to-Hip Ratio in Prediction of Nonalcoholic Fatty Liver Disease. Gastroenterol Res Pract. 2012; 2012:362147. PMC: 3369513. DOI: 10.1155/2012/362147. View

Spradling P, Bulkow L, Teshale E, Negus S, Homan C, Simons B . Prevalence and causes of elevated serum aminotransferase levels in a population-based cohort of persons with chronic hepatitis B virus infection. J Hepatol. 2014; 61(4):785-91. DOI: 10.1016/j.jhep.2014.05.045. View

Morales L, Flores Y, Leng M, Sportiche N, Gallegos-Carrillo K, Salmeron J . Risk factors for cardiovascular disease among Mexican-American adults in the United States and Mexico: a comparative study. Salud Publica Mex. 2014; 56(2):197-205. DOI: 10.21149/spm.v56i2.7335. View

BERGMEYER H, Horder M, Rej R . International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine.... J Clin Chem Clin Biochem. 1986; 24(7):481-95. View

10.

Pendino G, Mariano A, Surace P, Caserta C, Fiorillo M, Amante A . Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town. Hepatology. 2005; 41(5):1151-9. DOI: 10.1002/hep.20689. View

11.

Mendez-Sanchez N, Villa A, Chavez-Tapia N, Ponciano-Rodriguez G, Almeda-Valdes P, Gonzalez D . Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol. 2005; 4(1):52-5. View

12.

Ioannou G, Boyko E, Lee S . The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol. 2006; 101(1):76-82. DOI: 10.1111/j.1572-0241.2005.00341.x. View

13.

Denova-Gutierrez E, Huitron-Bravo G, Talavera J, Castanon S, Gallegos-Carrillo K, Flores Y . Dietary glycemic index, dietary glycemic load, blood lipids, and coronary heart disease. J Nutr Metab. 2010; 2010. PMC: 2911609. DOI: 10.1155/2010/170680. View

14.

Kunutsor S, Apekey T, Walley J . Liver aminotransferases and risk of incident type 2 diabetes: a systematic review and meta-analysis. Am J Epidemiol. 2013; 178(2):159-71. DOI: 10.1093/aje/kws469. View

15.

Flores Y, Yee Jr H, Leng M, Escarce J, Bastani R, Salmeron J . Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004. Am J Gastroenterol. 2008; 103(9):2231-8. PMC: 4462194. DOI: 10.1111/j.1572-0241.2008.02022.x. View

16.

Younossi Z, Stepanova M . Hepatitis C virus infection, age, and Hispanic ethnicity increase mortality from liver cancer in the United States. Clin Gastroenterol Hepatol. 2010; 8(8):718-23. DOI: 10.1016/j.cgh.2010.04.017. View

17.

Rojas R, Aguilar-Salinas C, Jimenez-Corona A, Shamah-Levy T, Rauda J, Avila-Burgos L . Metabolic syndrome in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Publica Mex. 2010; 52 Suppl 1:S11-8. DOI: 10.1590/s0036-36342010000700004. View

18.

Williams R . Global challenges in liver disease. Hepatology. 2006; 44(3):521-6. DOI: 10.1002/hep.21347. View

19.

Ascha M, Hanouneh I, Lopez R, Tamimi T, Feldstein A, Zein N . The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010; 51(6):1972-8. DOI: 10.1002/hep.23527. View

20.

Jiles R, Hughes E, Murphy W, Flowers N, McCracken M, Roberts H . Surveillance for certain health behaviors among states and selected local areas--Behavioral Risk Factor Surveillance System, United States, 2003. MMWR Surveill Summ. 2005; 54(8):1-116. View